Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Shares Traded Last Trade
  3.00 4.69% 67.00 171,127 09:29:25
Bid Price Offer Price High Price Low Price Open Price
65.00 69.00 67.00 64.50 64.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.51 -1.95 -2.33 59
Last Trade Time Trade Type Trade Size Trade Price Currency
11:19:54 O 1,016 66.52 GBX

Optibiotix Health (OPTI) Latest News

More Optibiotix Health News
Optibiotix Health Takeover Rumours

Optibiotix Health (OPTI) Discussions and Chat

Optibiotix Health Forums and Chat

Date Time Title Posts
26/5/202011:40OptiBiotix Health PLC - 7,601
26/5/202011:17OptiBiotix - The uncensored thread 19,643
26/5/202007:10OptiBiotix Health (Facts NOT Fiction)4,317
26/5/202001:57SentimentalRules AKA idoflykathy72
06/5/202008:58OptiBiotix - Better Science, Better Health. Better buy some!57,580

Add a New Thread

Optibiotix Health (OPTI) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
10:19:5566.521,016675.84O
10:07:0366.52500332.60O
09:57:2266.52500332.60O
09:47:3068.601,7431,195.70O
09:22:3367.7510,0006,775.00O
View all Optibiotix Health trades in real-time

Optibiotix Health (OPTI) Top Chat Posts

DateSubject
26/5/2020
09:20
Optibiotix Health Daily Update: Optibiotix Health Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 64p.
Optibiotix Health Plc has a 4 week average price of 53p and a 12 week average price of 24p.
The 1 year high share price is 88.50p while the 1 year low share price is currently 24p.
There are currently 87,940,551 shares in issue and the average daily traded volume is 398,127 shares. The market capitalisation of Optibiotix Health Plc is £58,920,169.17.
22/5/2020
20:34
spartan attack: htTps://www.globenewswire.com/news-release/2020/04/27/2022701/0/en/Update-on-Omega-Optibiotix-and-NAVs.html April 27, 2020 13:52 ET | Source: Seneca Growth Capital VCT PLC Seneca Growth Capital VCT Plc (the "Company") Partial Realisations of Ordinary Share Investment in Omega Diagnostics Group plc (“Omega”) and B Share Investment in Optibiotix Health plc (“Optibiotix”), and updated Ordinary Share and B Share Net Asset Values (“NAV”) Partial Realisations of Ordinary Share Investment in Omega and B Share Investment in Optibiotix Following the recent rise in Omega’s share price on AIM, the Company has sold a further 543,868 Omega shares realising £211,940. The Company has now sold a total of 1,693,868 Omega shares from the Ordinary Share pool since the year end, realising a total of £570,636 and generating a profit versus original cost of £328,430 (equivalent to an unaudited profit of 136%). The Company’s Ordinary Share pool retains 600,000 Omega shares. The Directors are also pleased to report that the Company has sold 150,000 Optibiotix shares from the B Share pool, realising £90,083 and generating a profit versus original cost of £30,083 (equivalent to an unaudited profit of 50%). The Company’s B Share pool retains 600,000 Optibiotix shares
20/5/2020
10:07
manc10: KREATURE DESPERATE ERR ERR THE DRINK NOT NICE ERR ERR LOL FLASH SALE ERR ERR SOME ONE BOUGHT 3 MILLION SHARES OF SBTX AT 18P ERR WHAT NOW ALL THIS POSTING AND THE SHARE PRICE IS UP SENTI HELP ME LOOOOOOOOOOOOOOL everybody loves a little bit of bobby brown especially walmart and boots lol 26p
19/5/2020
12:50
dire cons: manc10 19 May '20 - 12:23 - 18987 of 18996 0 0 0 on behalf of everybody who owns opti and sbtx we would like to thank the 3 stoogies for moving the share price higher well done ray senti and kreature Lol! This Spartan character is up to 1600+ posts in 13 days. Almost a prolific as Senti.......Oh wait!? PMSL!
19/5/2020
12:23
manc10: on behalf of everybody who owns opti and sbtx we would like to thank the 3 stoogies for moving the share price higher well done ray senti and kreature
09/5/2020
14:57
kreature: Very encouraging. Thanks Colin/manc..... —- manc109 May '20 - 13:08 - 3697 of 3701 0 0 0 OPTI from colin z on the no nutjob thread Deals 40-50 ongoing discussions at the moment, some of which have been going on for a while, “a number of years”. Won’t give more on H&B sales but has ‘surpassedR17; SoH’s expectations, he’s ‘pleased’; with all of the retail deals so far. Retailers give volume, not margin. Total number of deals is 62 (64 including the ones this week), majority of these are ‘still active’. 4-5 ‘not active’ e.g. Medicum?? distributor deal dead – OPTI have gone direct with Velinoff Pharma. Still looking at India retail. 40/62 deals now producing revenues. Fred helped to grow revenues for his division. 70% of deals are generating revenues within the first year of signing in 2020 vs. 30% in 2018. SoH doesn’t think SBTX shareholders appreciated the Croda deal. Cash / Revenue “We don’t expect to raise more money, focus this year is on reaching profitability” – doesn’t rule it out in future though to grow the company. Recently raised funds enough to sustain working capital needs for recent US and China deals. Q1 2020 prebiotic division (Fred Narbel) has reached profitability. Trading statement over next week. 2019 accounts waiting to come back from the auditors. Seed still selling c$1m a month in product. Revenue growth: 2500% prebiotics, 69% online (80-85% gross margin), 14% probiotics (n.b no context given re period). Future Looking to incorporate Slimbiome into bread and crisps: “Protein and slimbiome crisps”. Market trend towards healthy snacking, OPTI developing products to meet this. Granja Pocha to ‘prove’ they can take LPLDL into dairy. GMP still very ‘high risk’ (I believe this is US pharma LPLDL deal). Billion-dollar opportunity is unrealistic (SoH referring to bulletin board comments on what the company could be worth). When asked about 2022 pre-tax profits of £7-10m he came back with “We’re at the early stage of generating revenues” focus on this year getting to profitability. “Not going to predict two, three years down the line”. Prebiotic should be “very profitable” by the end of the year, probiotic division “not there yet”…220;quite a gap to fill”. Probiotics possible spinout on AIM/NASDAQ…Q. Why? A. Meetings facilitated by Goetz in Europe – potential investors concerned about the AIM listing and how the share price is not reflective of company progress – more influenced by bloggers than company news (TW called this out as a weak argument). SoH came back with NASDAQ companies’ valuations being 10-20x OPTI value, when compared – Americans realise the potential of the microbiome vs. Europeans. OPTI trying to expand US product listings (Seed, Costco, Walmart) to increase visibility of the company and its products that will help to support a future NASDAQ listing.
09/5/2020
13:08
manc10: OPTI from colin z on the no nutjob thread Deals 40-50 ongoing discussions at the moment, some of which have been going on for a while, “a number of years”. Won’t give more on H&B sales but has ‘surpassedR17; SoH’s expectations, he’s ‘pleased’; with all of the retail deals so far. Retailers give volume, not margin. Total number of deals is 62 (64 including the ones this week), majority of these are ‘still active’. 4-5 ‘not active’ e.g. Medicum?? distributor deal dead – OPTI have gone direct with Velinoff Pharma. Still looking at India retail. 40/62 deals now producing revenues. Fred helped to grow revenues for his division. 70% of deals are generating revenues within the first year of signing in 2020 vs. 30% in 2018. SoH doesn’t think SBTX shareholders appreciated the Croda deal. Cash / Revenue “We don’t expect to raise more money, focus this year is on reaching profitability” – doesn’t rule it out in future though to grow the company. Recently raised funds enough to sustain working capital needs for recent US and China deals. Q1 2020 prebiotic division (Fred Narbel) has reached profitability. Trading statement over next week. 2019 accounts waiting to come back from the auditors. Seed still selling c$1m a month in product. Revenue growth: 2500% prebiotics, 69% online (80-85% gross margin), 14% probiotics (n.b no context given re period). Future Looking to incorporate Slimbiome into bread and crisps: “Protein and slimbiome crisps”. Market trend towards healthy snacking, OPTI developing products to meet this. Granja Pocha to ‘prove’ they can take LPLDL into dairy. GMP still very ‘high risk’ (I believe this is US pharma LPLDL deal). Billion-dollar opportunity is unrealistic (SoH referring to bulletin board comments on what the company could be worth). When asked about 2022 pre-tax profits of £7-10m he came back with “We’re at the early stage of generating revenues” focus on this year getting to profitability. “Not going to predict two, three years down the line”. Prebiotic should be “very profitable” by the end of the year, probiotic division “not there yet”…220;quite a gap to fill”. Probiotics possible spinout on AIM/NASDAQ…Q. Why? A. Meetings facilitated by Goetz in Europe – potential investors concerned about the AIM listing and how the share price is not reflective of company progress – more influenced by bloggers than company news (TW called this out as a weak argument). SoH came back with NASDAQ companies’ valuations being 10-20x OPTI value, when compared – Americans realise the potential of the microbiome vs. Europeans. OPTI trying to expand US product listings (Seed, Costco, Walmart) to increase visibility of the company and its products that will help to support a future NASDAQ listing.
05/5/2020
18:43
manc10: Last time a placing happened the share price rose 5p . Why because the Money was needed for product to sell. its called speculate to accumulate. opti pay for the product eg powder some times opti pay up front for produce other times there are other agreements .then they sell it on for a profit der and why not use a 20 million pound asset you got for 250k eg sbtx .if you need to fund a huge deal it not rocket science loooooool
05/5/2020
12:28
sentimentrules: "Shares to avoid at all costs If you asked me what is the easiest way to lose money then I'd say (in general) invest in a company with a multi-million pound capitalisation that has next to zero revenues and clearly needs paid cheerleaders to try to keep the share price propped up until the next dilutive fund raising. True jam tomorrow companies. Here's a quick list of companies to avoid at all costs. OptiBiotix (Opti), Premiatha Health (Nipt), Concepta and Big Sofa Technologies."
27/4/2020
12:11
manc10: booooooooooooooooooooooooooooooooooooooooooooooooom anybody seen raytard joking apart the best thing to happen to opti is raytard kreature and senti you dont half get the share price moving thanks from all lth lol
23/4/2020
11:39
sentimentrules: Whatever comforts you nobby..in your time of opti share price destruction
Optibiotix Health share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
OPTI
Optibiotix..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200526 10:53:02